Abstract
Indocyanine green (ICG) angiography was first approved by the Food and Drug Administration for human use in the 1956. Prior to its use in chorioretinal angiograms, ICG was used to measure blood flow and track cardiac output. It was only in 1969 when two researchers, Kyuga Kogure and Earl Choromokos from the University of Miami, first used ICG to create more accurate angiograms. In the following years, researchers were able to hone the underlying science of this new form of angiography. As time passed and technology advanced, the application of ICG in clinical practice became widespread. Today ICG is used to diagnose and monitor the progression of retinal and choroidal diseases affecting millions of individuals across the globe. ICG utilizes the injection of indocyanine green dye into a patient’s bloodstream to visualize abnormalities of the choroid and retina by evaluating choroidal circulation. ICG angiography is useful in the diagnosis and management of occult choroidal neovascularization in age-related macular degeneration and may be used in other inflammatory conditions with central serous chorioretinopathy. ICG angiography offers advanced imaging for improved monitoring and treatment of a wide variety of choroidal and retinal diseases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Baker KJ (1966) Binding of sulfobromophthalein (BSP) sodium and indocyanine green (ICG) by plasma alpha-1 lipoproteins. Proc Soc Exp Biol Med 122(4):957–963
Guex-Crosier Y, Herbort CP (1997) Prolonged retinal arterio-venous circulation time by fluorescein but not by indocyanine green angiography in birdshot chorioretinopathy. Ocul Immunol Inflamm 5(3):203–206
Yannuzzi LA et al (1994) Indocyanine green videoangiography: current status. Eur J Ophthalmol 4(2):69–81
Hayashi K, Hasegawa Y, Tokoro T (1986) Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol 9(1):37–41
Scheider A, Schroedel C (1989) High resolution indocyanine green angiography with a scanning laser ophthalmoscope. Am J Ophthalmol 108(4):458–459
Yannuzzi LA et al (1992) Digital indocyanine green videoangiography and choroidal neovascularization. Retina 12(3):191–223
Borruat FX, Auer C, Piguet B (1995) Choroidopathy in multiple evanescent white dot syndrome. Arch Ophthalmol 113(12):1569–1571
Bernasconi O, Auer C, Herbort CP (1997) Recurrent toxoplasmic retinochoroiditis. Significance of perilesional satellite dark dots seen by indocyanine green angiography. Ocul Immunol Inflamm 5(3):207–211
Giani A, Pellegrini M, Carini E, Peroglio Deiro A, Bottoni F, Staurenghi G (2012 Jun 26) The dark atrophy with indocyanine green angiography in Stargardt disease. Invest Ophthalmol Vis Sci 53(7):3999–4004
Arevalo JF (ed) (2009) Retinal angiography and optical coherence tomography. Springer, New York
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Ethics declarations
Stephen H. Tsang receives financial support from Abeona Therapeutics, Inc and Emendo. He is also the founder of Rejuvitas and is on the scientific and clinical advisory board for Nanoscope Therapeutics.
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Baddam, D.O., Ragi, S.D., Tsang, S.H., Ngo, W.K. (2023). Protocol for Indocyanine Green Angiography. In: Tsang, S.H., Quinn, P.M. (eds) Retinitis Pigmentosa. Methods in Molecular Biology, vol 2560. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2651-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2651-1_16
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2650-4
Online ISBN: 978-1-0716-2651-1
eBook Packages: Springer Protocols